EssilorLuxottica stock trades steady as Paris listing holds above EUR 159

EssilorLuxottica (FR0000033219) stock is trading at EUR 159.80 on Euronext Paris as of August 18, 2026, based on the latest closing order data showing multiple trades executed at that level late in the session Boursorama price overview. For US investors following the over-the-counter line, recent data show the EssilorLuxottica American depositary receipts changing hands at $94.78 on August 17, 2026, giving the group a market capitalization of $87.33 billion Ad-hoc market snapshot.

Market valuation and recent trading range

The Paris listing data indicate that EssilorLuxottica shares last changed hands at EUR 159.80 in continuous trading on August 18, 2026, with several transactions printed at that price in the closing auction window Boursorama price overview. Converted at prevailing exchange rates, that level lines up closely with the $94.78 quote seen in US trading on August 17, 2026, where the intraday range stretched from a low of $93.67 to a high of $94.79 Ad-hoc market snapshot. This range leaves the stock comfortably above the $90 mark that acted as a reference level earlier in August Ad-hoc market snapshot.

Based on the $94.78 quote and the stated equity valuation, the company’s market capitalization currently stands at $87.33 billion as of August 17, 2026 Ad-hoc market snapshot. For investors, that market cap anchors EssilorLuxottica among the larger global consumer and healthcare names, with the stock’s year-to-date performance referenced against a starting price of $158.42 per share, from which it has declined 40.6 percent by mid-August 2026 MarketBeat EssilorLuxottica profile. The combination of a lower share price and steady large-cap valuation reflects the impact of prior gains as well as the company’s earnings outlook.

Earnings backdrop and fundamentals

The latest market commentary summarizing EssilorLuxottica highlights that the group’s current valuation of $87.33 billion in mid-August 2026 is supported by its global leadership in eyewear and lens manufacturing Ad-hoc market snapshot. The same overview notes that the stock’s year-opening level of $158.42 has given way to the current $94.05 to $94.78 area, translating into a 40.6 percent decline since the start of 2026 MarketBeat EssilorLuxottica profile. While detailed revenue and net income figures for the most recent half-year are not included in these snapshots, the valuation and price performance frame how the market is discounting the company’s underlying earnings power.

From an earnings perspective, the reference data imply that investors are recalibrating EssilorLuxottica’s multiples as the share price shifts lower while the business remains profitable MarketBeat EssilorLuxottica profile. A move from $158.42 to $94.05 over the year-to-date period means the stock has given up 40.37 percent of its value, rounded in the commentary to a 40.6 percent decline MarketBeat EssilorLuxottica profile. For long-term shareholders, that contraction between January 2026 and mid-August 2026 changes the implied price-to-earnings and enterprise-value-to-EBITDA ratios on the latest available earnings, potentially making the shares look more reasonable relative to historic levels, provided earnings remain resilient.

Analyst and index context

Market data providers tracking EssilorLuxottica explain that the company’s shares are followed by a broad set of equity analysts given its inclusion in major European benchmarks and its dual presence in lenses and frames MarketBeat EssilorLuxottica profile. The reference overview shows that consensus expectations embed ongoing profit generation, even as the share price has corrected from early-2026 highs, leaving room for investors to debate whether the 40.6 percent year-to-date drop already discounts macro and sector risks MarketBeat EssilorLuxottica profile. With a current market value of $87.33 billion as of August 17, 2026, EssilorLuxottica still ranks as a core holding for many Europe-focused funds Ad-hoc market snapshot.

The cross-listing between Euronext Paris and the over-the-counter US line gives investors flexibility in how they access exposure to EssilorLuxottica Ad-hoc market snapshot. On the home market, the last quoted price of EUR 159.80 on August 18, 2026 reflects local currency conditions and European investor sentiment Boursorama price overview. In the US, the $94.78 quote on August 17, 2026 provides a dollar-based reference that can be compared with other US-traded consumer and healthcare names Ad-hoc market snapshot.

Flagship eyewear portfolio

EssilorLuxottica’s investment case is tightly linked to its portfolio of branded eyewear, which combines prescription lenses with fashion and sports frames under globally recognized labels. The group produces and distributes glasses for consumers who need vision correction as well as sunglasses and performance eyewear for outdoor and athletic use. This mix of medical necessity and discretionary style creates diversified demand across economic cycles, supporting the company’s revenue streams.

EssilorLuxottica stock on Euronext Paris

On Euronext Paris, EssilorLuxottica stock is quoted in euros, with the last observed price of EUR 159.80 as of the August 18, 2026 session close Boursorama price overview. In US trading, the corresponding over-the-counter line most recently closed at $94.78 on August 17, 2026, implying a market capitalization of $87.33 billion at that time Ad-hoc market snapshot. Investors evaluating the shares can use these dated reference levels to gauge how EssilorLuxottica trades relative to its recent high of $158.42 at the start of 2026, from which it has fallen by 40.6 percent as of mid-August 2026 MarketBeat EssilorLuxottica profile.

Fact box

Company: EssilorLuxottica S.A.
ISIN: FR0000033219
Ticker: EL
Exchange: Euronext Paris
Price (as of August 18, 2026, 5:35 p.m. CET): EUR 159.80
Market cap: $87.33 billion (as of August 17, 2026)
Sector / Industry: Consumer goods / Eyewear and vision care
Index membership: Major European equity benchmarks

Read more

Further details on EssilorLuxottica’s financials, strategy, and shareholder information are available via the company’s investor relations website.